“fate-therapeutics” Archives

Entry Author Date Location
The Icos Alumni Guide, Trubion CEO Resigns, OVP Leads $30M Fate Deal, & More Seattle-Area Life Sciences News 11/19/09 Seattle
A Week of Woe for Genzyme, A CPR App for Your iPhone, A Better Treatment for Opioid Dependence, and More Boston-Area Life Sciences News 11/19/09 Boston
Bing Partners with Wolfram Alpha, OVP Leads $30M Fate Deal, Redfin Rakes In $10M, & More Seattle-Area Deals News 11/17/09 Seattle
Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop “Industrialized” Stem Cells 11/16/09 National
Fate Therapeutics Lands $30,000,000 Series B Funding Round 11/16/09 San Diego
Who Will Create the Future of San Diego Biotech? Xconomy Event Will Gather Star Innovators From Inside and Outside the Region 11/10/09 San Diego
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News 10/22/09 Seattle
Faster, Cheaper Stem Cells: Fate Therapeutics Co-Founder, With Scripps Team, Finds Key 10/18/09 National
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News 10/01/09 Seattle
Sequenom Starts Over After Purge, Patent Lawsuits Flying Over Gene Sequencing Technologies, Zogenix Prepares for Needle-Free Injections, & More San Diego Biotech News 10/01/09 San Diego
Fate Therapeutics Growing Fast on “Industrialized” Stem Cell Technology 09/30/09 National
New VC in Boston: Arch Venture Partners Opens Small Office With Eye Toward Basic Science, Multidisciplinary Collaborations 09/21/09 Boston
Vulcan’s Biotech Windfall, Tekmira Tackles RNAi Delivery, The $1,000 Genome Debate, & More Seattle-Area Life Sciences News 05/28/09 Seattle
Amylin Pharmaceuticals Gets New Directors (But Who Are They?), Ophthonix and Vical Raise Capital, Metabasis Cuts Back—Again, & More San Diego Life Sciences News 05/28/09 San Diego
Fate Therapeutics Starts First Clinical Trial of Drug to Boost Stem Cell Transplants 05/27/09 San Diego
Amylin Nears Endgame With Icahn, Sciele Pharma Declares Victory in Buyout, Nanogen Files Bankruptcy, & More San Diego Life Sciences News 05/21/09 San Diego
Biogen Idec Rebuts Icahn Attack, GlaxoSmithKline Quietly Spins Off Tempero Pharmaceuticals, Knome Launches Cheaper Sequencing Service, & More Boston-Area Life Sciences News 05/20/09 Boston
Stem Cell Tech in Fate’s Hands 05/15/09 San Diego
Merck Makes GlycoFi Center of its Biogenerics Strategy, Biogen Says Tysabri Might Promote Remyelination, Stemgent Teams with Fate, & More Boston-Area Life Sciences News 04/30/09 Boston
Brightcove Forges Adobe Alliance, Investors Give in to DemandWare’s $15M Demands, Fate Therapeutics and Stemgent Team Up on Stem Cell Tech, & More Boston-Area Deals News 04/24/09 Boston
Fate Therapeutics and Stemgent Team Up to Offer Stem Cell Advances to the Research Market 04/23/09 San Diego
Obama’s Stem Cell Reversal Sparks Deals, Qualcomm’s MediaFLO Revealed, Nokia’s Wireless Mapping, & More SD BizTech News 03/16/09 San Diego
Fate Therapeutics Adds Scientific Muscle, Advancing Stem Cell Technology into First Clinical Trial 03/13/09 San Diego
Venrock’s Bryan Roberts: Shakeout Is Coming to VCs, Not Just Companies 02/05/09 National
Seattle’s Pharma Godfather, Ben Shapiro, Sees Potential Here To Transform Medicine Despite Setbacks 11/17/08 Seattle
Gov. Gregoire Urges Biotechies to “Stay Focused”; UW Makes its Biotech Business Case, And A Host of Startups Debut 10/28/08 Seattle
New Biotech Biz Models (and the Tested Bob Langer-Terry McGuire Approach) Emerge at Xconomy Forum 09/25/08 Boston
Discovery: The Soul of Biotech, the Place For True Believers, and a Retro Way to Bring it Back 09/08/08 Seattle
Announcing Xconomy’s Next Forum: How to Build A Life Sciences Company 08/25/08 Boston
Fate Therapeutics Names Executive Chairman 05/14/08 Boston
Page 3 of 4 « previous page · next page »